IntrinsicIntrinsic
← Scroll for more →

Financial Statements — MBIO

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents15.1516.2617.2718.9812.6614.236.843.534.271.346.239.5615.3958.1075.6691.36107.37122.22109.62120.88
Total Current Assets----17.5919.3613.0514.918.616.067.329.2411.3513.5922.5861.1378.8594.45109.38124.15111.71121.95
Property, Plant & Equipment----0.000.000.000.000.370.420.472.963.223.503.798.669.3910.0510.2010.5111.0510.44
Total Non-current Assets*----0.000.000.000.000.701.141.205.356.406.986.5112.4813.5714.3912.5312.8113.4612.76
Total Assets15.6116.5817.5919.3613.0514.919.317.198.5214.5917.7420.5729.0973.6192.42108.84121.91136.96125.17134.71
Accounts Payable5.385.325.416.917.508.349.4912.0613.1915.0114.0212.7111.6811.4413.7312.8110.169.629.749.83
Total Current Liabilities7.927.847.919.4410.0011.1512.6115.0415.9217.4415.3714.1712.8612.6715.1113.5610.9810.7810.8210.46
Total Non-current Liabilities*0.150.150.150.150.150.150.570.810.932.102.252.392.5131.1231.0430.9528.9228.851.962.03
Total Liabilities8.077.998.069.5910.1511.3013.1815.8516.8519.5417.6216.5615.3743.7946.1544.5139.9039.6312.7712.49
Retained Earnings(400.67)(399.60)(398.64)(398.11)(397.64)(396.88)(396.72)(395.77)(394.36)(386.16)(380.97)(372.35)(362.30)(346.06)(329.37)(309.73)(290.74)(271.64)(251.84)(231.79)
Total Stockholder Equity7.558.609.539.772.893.61(3.87)(8.66)(8.33)(4.94)0.124.0113.7129.8246.2764.3382.0197.33112.40122.21
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Selling, General & Admin0.950.880.990.960.791.22(0.22)1.401.531.432.182.133.062.322.403.393.083.352.652.36
Total Operating Expenses1.171.060.670.620.890.251.021.468.545.238.7410.3113.8916.3219.4318.8518.2419.6420.1217.08
Operating Income(1.17)(1.06)(0.67)(0.62)(0.88)(0.25)(1.02)(1.46)(8.54)(5.23)(8.74)(10.31)(13.89)(16.32)(19.43)(18.85)(18.24)(19.64)(20.12)(17.08)
Net Income(1.07)(0.95)(0.54)(0.47)(0.76)(0.15)(0.95)(1.41)(8.20)(5.19)(8.62)(10.06)(16.23)(16.69)(19.63)(19.00)(19.10)(19.80)(20.05)(17.00)
Basic EPS(0.16)(0.14)(0.08)(0.07)(0.19)(0.05)(37.72)(0.04)(0.35)(0.46)(0.71)(1.23)(2.00)(2.06)(0.18)(0.18)(0.19)(0.20)----
Diluted EPS(0.16)(0.14)(0.08)(0.07)(0.19)(0.05)(37.72)(0.04)(0.35)(0.46)(0.71)(1.23)(2.00)(2.06)(0.17)(0.18)(0.19)(0.21)----
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(0.97)(1.01)(1.72)(0.82)(1.34)(1.39)(2.00)(1.76)(2.33)(5.32)(7.25)(12.02)(12.39)(17.81)(15.29)(15.91)(17.57)(16.29)(14.70)(11.29)
Capital Expenditures------------0.000.000.00--0.030.000.030.000.100.980.311.331.380.46
Free Cash Flow*------------(2.00)(1.76)(2.33)--(7.28)(12.02)(12.43)(17.81)(15.38)(16.89)(17.88)(17.62)(16.08)(11.75)
Investing Cash Flow0.000.000.000.000.001.170.000.000.000.00(0.03)5.95(0.03)0.00(0.42)(0.89)(0.31)(1.33)(1.48)(0.99)
Financing Cash Flow(0.14)0.000.007.15(0.23)7.624.941.015.270.053.960.25(30.29)0.000.000.803.0330.224.923.24
← Scroll for more columns →

* Derived from reported values